Skip to main content

Premenstrual Syndrome

1
Pipeline Programs
6
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
1
sertralinePhase 41 trial
Krill oilN/A1 trial
Active Trials
NCT06584669Completed179Est. Aug 2013
NCT00318773Completed174Est. Feb 2008
City Therapeutics
City TherapeuticsCAMBRIDGE, MA
1 program
Auricular acupressure therapyN/A1 trial
Active Trials
NCT06981533CompletedEst. Jun 2025
Bayer
BayerLEVERKUSEN, Germany
1 program
Drospirenone and ethinyl estradiolN/A1 trial
Active Trials
NCT00633360Completed32Est. May 2011
Vivance
VivanceSingapore - Singapore
1 program
Kaia Relief - Cycle SystemN/A1 trial
Active Trials
NCT07876050Recruiting45Est. Jan 2027
Biomed
BiomedAustralia - Sydney
1 program
Shatavari Root ExtractN/A1 trial
Active Trials
NCT07441096Not Yet Recruiting60Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Human BioSciencessertraline
VivanceKaia Relief - Cycle System
BiomedShatavari Root Extract
City TherapeuticsAuricular acupressure therapy
Human BioSciencesKrill oil
BayerDrospirenone and ethinyl estradiol

Clinical Trials (6)

Total enrollment: 490 patients across 6 trials

Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)

Start: Feb 2002Est. completion: Feb 2008174 patients
Phase 4Completed
NCT07876050VivanceKaia Relief - Cycle System

A Clinical Trial to Evaluate the Effects of the Kaia Relief - Cycle System on Premenstrual Symptom Severity, Menstrual Discomfort, and Overall Well-Being in Premenopausal Women.

Start: Oct 2026Est. completion: Jan 202745 patients
N/ARecruiting
NCT07441096BiomedShatavari Root Extract

Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women

Start: Mar 2026Est. completion: Jul 202660 patients
N/ANot Yet Recruiting
NCT06981533City TherapeuticsAuricular acupressure therapy

Auricular Acupressure for Premenstrual Syndrome in Female Students

Start: Apr 2025Est. completion: Jun 2025
N/ACompleted

Investigation of Krill Oil in Women with Premenstrual Syndrome

Start: Feb 2012Est. completion: Aug 2013179 patients
N/ACompleted
NCT00633360BayerDrospirenone and ethinyl estradiol

The Oral Contraceptive Pill for Premenstrual Worsening of Depression

Start: Feb 2008Est. completion: May 201132 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 490 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.